These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9580544)

  • 1. The safety of pyrimethamine and sulfadoxine for the prevention of Pneumocystis carinii pneumonia.
    Teira R; Virosta M; Muñoz J; Zubero Z; Santamaría JM
    Scand J Infect Dis; 1997; 29(6):595-6. PubMed ID: 9580544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients.
    Ruf B; Schürmann D; Bergmann F; Schüler-Maué W; Grünewald T; Gottschalk HJ; Witt H; Pohle HD
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):325-9. PubMed ID: 8354297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
    J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse reactions associated with pyrimethamine-sulfadoxine prophylaxis for Pneumocystis carinii infections in AIDS.
    Navin TR; Miller KD; Satriale RF; Lobel HO
    Lancet; 1985 Jun; 1(8441):1332. PubMed ID: 2860516
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
    Torre-Cisneros J; De la Mata M; Pozo JC; Serrano P; Briceño J; Solórzano G; Miño G; Pera C; Sánchez-Guijo P
    Clin Infect Dis; 1999 Oct; 29(4):771-4. PubMed ID: 10589886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
    Pearson RD; Hewlett EL
    Ann Intern Med; 1987 May; 106(5):714-8. PubMed ID: 3551713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of pyrimethamine/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients with AIDS.
    Bessesen MT; Miller LA; Cohn DL; Bartlett S; Ellison RT
    Clin Infect Dis; 1995 Mar; 20(3):730-1. PubMed ID: 7756514
    [No Abstract]   [Full Text] [Related]  

  • 9. Leads from the MMWR. Fansidar-associated fatal reaction in an HIV-infected man.
    JAMA; 1988 Oct; 260(15):2193. PubMed ID: 3262778
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person.
    Raviglione MC; Dinan WA; Pablos-Mendez A; Palagiano A; Sabatini MT
    Arch Intern Med; 1988 Dec; 148(12):2683-5. PubMed ID: 3264143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and Toxoplasma encephalitis].
    Teira R; Virosta M; Baraia-Etxaburu J; Muñoz J; Zubero Z; Cisterna R; Santamaría JM
    Enferm Infecc Microbiol Clin; 1999; 17(7):347-9. PubMed ID: 10535188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine.
    Gottlieb MS; Knight S; Mitsuyasu R; Weisman J; Roth M; Young LS
    Lancet; 1984 Aug; 2(8399):398-9. PubMed ID: 6147471
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS.
    Payen MC; De Wit S; Sommereijns B; Clumeck N
    Biomed Pharmacother; 1997; 51(10):439-45. PubMed ID: 9863502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three cases of acquired immunodeficiency syndrome complicated with toxic epidermal necrolysis.
    Kimura S; Oka S; Mohri H; Mitamura K; Shimada K
    Jpn J Med; 1991; 30(6):553-8. PubMed ID: 1798215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.
    Hellgren U; Rombo L; Berg B; Carlson J; Wiholm BE
    Br Med J (Clin Res Ed); 1987 Aug; 295(6594):365-6. PubMed ID: 2958104
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine.
    Bamber MG; Elder AT; Gray JA; Minns RA
    J Infect; 1986 Jul; 13(1):31-3. PubMed ID: 3734464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fansidar and Pneumocystis carinii pneumonia.
    Frissen PH; Stronkhorst A; Eeftinck Schattenkerk JK; Danner SA
    Ann Intern Med; 1988 Apr; 108(4):638-9. PubMed ID: 3258139
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stevens-Johnson syndrome and granulopenia induced by sulfadoxine-pyrimethamine (Fansidar)].
    Ligthelm RJ; van Zwienen J; Stuiver PC; Djajadiningrat AP
    Ned Tijdschr Geneeskd; 1983 Sep; 127(38):1735-7. PubMed ID: 6633717
    [No Abstract]   [Full Text] [Related]  

  • 19. [Stevens-Johnson syndrome in a patient treated with quinine and pyrimethamine-sulfadoxine].
    Gascón Brustenga J; Merlos Pujol A; Bada Ainsa JL
    Med Clin (Barc); 1986 Dec; 87(19):821-2. PubMed ID: 3821238
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral manifestations of toxic epidermal necrolysis (TEN) in patients with AIDS: report of five cases.
    Schmidt-Westhausen A; Grünewald T; Reichart PA; Pohle HD
    Oral Dis; 1998 Jun; 4(2):90-4. PubMed ID: 9680896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.